Advent Life Sciences
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Romania, Bulgaria
Industries Focus
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Healthcare Technology
- Healthcare Equipment
- Healthcare IT
- Healthcare Logistics
- Healthcare Consulting
- Healthcare Marketing
- Life Sciences Research
- Healthcare Supply Chain
- Healthcare Analytics
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2006
Advent Life Sciences is a prominent venture capital firm based in the United Kingdom, focusing on early-stage investments in the life sciences sector. The firm is dedicated to supporting innovative companies that are developing groundbreaking therapies and technologies to address unmet medical needs. Advent Life Sciences partners with entrepreneurs and management teams to accelerate the growth of their portfolio companies, providing not only capital but also strategic guidance and operational support.
The firm's investment strategy encompasses a broad spectrum of life sciences sectors, including biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health. Advent Life Sciences seeks to invest in companies that are at the forefront of scientific and technological advancements, aiming to bring transformative solutions to the healthcare market. The firm is particularly interested in opportunities that have the potential to make a significant impact on patient care and outcomes.
With a team of experienced professionals, Advent Life Sciences has built a strong track record of successful investments. The firm's approach combines deep industry knowledge with a collaborative partnership model, fostering long-term relationships with portfolio companies. Advent Life Sciences is committed to driving innovation in the life sciences industry, supporting the development of therapies and technologies that improve health and quality of life worldwide.
Requirements
- Innovative life sciences companies with strong management teams
- Potential for significant impact on patient care
- Alignment with Advent Life Sciences' strategic focus areas
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- KaNDy Therapeutics
- Nalu Medical
- Glycomine
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$19.95
-
$39.95
-
$99.00
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Advent Life Sciences?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim